In the last trading session, 14.53 million shares of the Helius Medical Technologies Inc (NASDAQ:HSDT) were traded, and its beta was 1.14. Most recently the company’s share price was $0.38, and it changed around -$0.13 or -26.23% from the last close, which brings the market valuation of the company to $0.20M. HSDT currently trades at a discount to its 52-week high of $24.00, offering almost -6215.79% off that amount. The share price’s 52-week low was $0.48, which indicates that the current value has fallen by an impressive -26.32% since then. We note from Helius Medical Technologies Inc’s average daily trading volume that its 10-day average is 26.79 million shares, with the 3-month average coming to 3.97 million.
Helius Medical Technologies Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended HSDT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Instantly HSDT has showed a red trend with a performance of -26.23% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.8500 on recent trading dayincreased the stock’s daily price by 79.46%. The company’s shares are currently down -96.27% year-to-date, but still down -56.59% over the last five days. On the other hand, Helius Medical Technologies Inc (NASDAQ:HSDT) is -90.98% down in the 30-day period. We can see from the shorts that 62031.0 shares have been sold at a short interest cover period of 1.98 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 63.29%.
HSDT Dividends
Helius Medical Technologies Inc’s next quarterly earnings report is expected to be released on 2025-Apr-30.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 10.91% of Helius Medical Technologies Inc shares, and 6.31% of them are in the hands of institutional investors. The stock currently has a share float of 7.09%.
